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The World Bank, the Gates Foundation and the World
Health Organization promote national child deworming
programmes in developing countries.1 They assert these
programmes will improve nutritional status, health and
school performance, and hence contribute to economic
growth. Indeed, the World Health Organization states that
deworming contributed to Japan’s economic boom in the
1950s,2 and Nobel Laureates meeting in Copenhagen
ranked deworming as the fourth most important interven-
tion to solve the health problems of the whole world.3
Surprisingly, the evidence base for these claims from con-
trolled studies is limited. Critically, according to the
Cochrane review which two of us author, there is quite
good evidence of no effect for the main biomedical out-
comes in deworming, making the broader societal benefits
on economic development barely credible (Figure 1).4
Nevertheless, the advocates increasingly rely on a single
large quasi-randomized trial carried out in Kenya, published
in 2004 in Econometrica,5 which reports school attendance.
This study has been highly influential. The International
Initiative for Impact Evaluation commissioned the London
School of Hygiene and Tropical Medicine (LSHTM) to
replicate the analysis, as the original analysis is ‘based on
econometric approaches and used a language and format
that would be unfamiliar to many health care researchers’.6
The replication aimed to provide detail of the methods and
reporting in line with the CONSORT statement. The team
are internationally recognized, independent and meticulous
in their approach. They agreed a protocol, carefully
checked and corrected the raw data, and then re-ran their
prespecified analysis.6
Their first paper is a pure replication,7 exactly repeating
the authors’ original analysis. This paper clarifies some
methodological details not provided in the original paper,
but it also uncovers a series of important coding and ana-
lysis errors. Some of the corrected results are consistent
with the original findings, but others are quite different.
Most notably, the much quoted ‘positive externalities’—
where the benefits of treating children in one school ‘spill
over’ to benefit children in adjacent schools—vanish in
their corrected analysis.
Their second paper uses approaches more familiar to
epidemiologists, and allows a more thorough exploration
of the data.8 There are substantial amounts of missing in-
formation, and some unexpected patterns that are difficult
to explain. For example, there is a correlation between the
number of observations in each school and the reported
attendance, with more observations associated with lower
attendance reported—except in some of the intervention
groups, where more frequent observation is associated
with better attendance. This raises the possibility that the
process of observation influenced outcome reporting and
this was different in control and intervention groups.
The second paper confirms an association with
higher attendance in the deworming schools when strati-
fied by year, but found the combined estimate across years
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was much larger, and the authors caution the validity
of the combined year estimate: this may be due to the step-
ped-wedge design where the combined year estimate in-
cludes a before and after comparison; or it may be due to
the problems with secular and group effects of the number
of observations of school attendance varying. To further
complicate matters, there was also a concurrent ‘School
Assistance Program’ (SAP) evaluating five other interven-
tions in 27/75 of the study schools, which was not part of
the randomized intervention. Attendance patterns differed
on the basis of involvement in the SAP, which the authors
suggest could well lead to bias.8
One of the critical points the LSHTM papers make is
that the administration of the deworming drugs was part
of a ‘complex health education and drug treatment inter-
vention’.8 The intervention schools also received regular
public health lectures, wall charts and teacher training on
worm prevention. Interestingly, the pure replication shows
very similar impacts of the intervention on children in the
intervention schools irrespective of whether they took the
deworming medicine or not.7 For Miguel and colleagues,
they term this as ‘indirect within-school effects’ of
deworming, but equally the effects could be due to the
non-specific effects of the health promotion interventions
in the intervention schools.
So where does this take us? There is a small effect on
school attendance for sure, but this should not be over-
interpreted, as the LSHTM authors say, given the concerns
raised regarding the risk of bias, and the independent ef-
fects on school attendance of the programme of health pro-
motion. In addition, the study shows that allocation to the
deworming group does not influence student progress, as
the re-analysis shows clearly no evidence of a difference in
examination performance between deworming and control
groups.7,8
In the context of the global evidence base, there is only
one other study that has examined school attendance with
no obvious effect shown.4 Given all these uncertainties, we
simply don’t know if there is truly an effect on school
attendance from the data, in taking all these factors into
account formally in a GRADE analysis.4 But what weak-
ens the case of deworming still further is that there is now
quite good evidence of no effect for most of the main out-
comes (Figure 1), including nutritional status, haemoglo-
bin, cognition and school performance. This is important
because without these effects it seems implausible that
Figure 1. Conceptual framework used to underpin the effects of deworming programmes on economic growth in developing countries.
Contemporary evidence questions this model, as there is now quite good contemporary evidence, summarized in the Cochrane review, that these
programmes have little or no effect on the main effects or mediating pathways4 (reproduced with permission).
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deworming itself would have an independent effect on
school attendance or economic development.
Obviously children infected with worms should be
treated. Trials from over 20 years ago in an area of Kenya
where all the children were heavily infected showed bene-
fit. Another trial in India showed benefit, but subsequent
trials in the same area failed to show an effect.4,9 So
deworming may have helped in these exceptional, heavily
infected, untreated populations from another decade, but
this is scarcely a solid base for contemporary policy: public
health nutrition has changed, worm burden has declined
and this probably accounts for the lack of effect on bio-
medical outcomes in contemporary studies.10
We have been perplexed by the unquestioning belief
behind deworming in the advocates, and have found it is
deep rooted in American history. The Rockefeller Sanitary
Commission in 1909 sought to eradicate hookworm in the
Southern USA population, where it was seen as a cause of
‘some of the proverbial laziness of the poorer classes’ and
to improve worker productivity; these were extended with
the Rockefeller International Health Commission estab-
lished in 1913.11 The beliefs and assumptions appear to
continue, with ‘Deworm the World’ aiming to deworm
220 million children in India during 2015.12
What have we learned from this? Certainly that replica-
tion is a valuable process, not least for errors that have the
potential to mislead, but also to provide a much better inter-
pretation of the potential biases in studies. In terms of poli-
cies in deworming, it suggests donors and Nobel Prize
winners need to be aware of their prior assumptions, and
base decisions on the all the evidence from reliable studies
within a systematic review, not just select a single study.
They need to look at all relevant outcomes, not just one.
They need to consider bias and confounding. Our view is
that current promotion of community deworming is certainly
a panacea: a single solution to multiple problems in low- and
middle-income countries, and that the belief that deworming
will impact substantially on economic development seems
delusional when you look at the results of reliable controlled
trials. This is a view, based on over 15 years of engagement
with critically appraising the literature in this field.13
We recommend anyone responsible for public or phil-
anthropic money going to large scale deworming to
read these replication studies, the original publication, the
authors’ responses to the replication and the 2015 version
of the Cochrane review that includes corrections from
these replications plus data from five further studies,
including the recently published DEVTA study of 2 million
children.4,14 Then make up your own mind.
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